TY - JOUR
T1 - Ageing with elegans
T2 - a research proposal to map healthspan pathways
AU - Luyten, Walter
AU - Antal, Peter
AU - Braeckman, Bart P.
AU - Bundy, Jake
AU - Cirulli, Francesca
AU - Fang-Yen, Christopher
AU - Fuellen, Georg
AU - Leroi, Armand
AU - Liu, Qingfei
AU - Martorell, Patricia
AU - Metspalu, Andres
AU - Perola, Markus
AU - Ristow, Michael
AU - Saul, Nadine
AU - Schoofs, Liliane
AU - Siems, Karsten
AU - Temmerman, Liesbet
AU - Smets, Tina
AU - Wolk, Alicja
AU - Rattan, Suresh I.S.
N1 - Publisher Copyright:
© 2016, Springer Science+Business Media Dordrecht.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Human longevity continues to increase world-wide, often accompanied by decreasing birth rates. As a larger fraction of the population thus gets older, the number of people suffering from disease or disability increases dramatically, presenting a major societal challenge. Healthy ageing has therefore been selected by EU policy makers as an important priority (http://www.healthyageing.eu/european-policies-and-initiatives); it benefits not only the elderly but also their direct environment and broader society, as well as the economy. The theme of healthy ageing figures prominently in the Horizon 2020 programme (https://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing), which has launched several research and innovation actions (RIA), like “Understanding health, ageing and disease: determinants, risk factors and pathways” in the work programme on “Personalising healthcare” (https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/693-phc-01-2014.html). Here we present our research proposal entitled “ageing with elegans” (AwE) (http://www.h2020awe.eu/), funded by this RIA, which aims for better understanding of the factors causing health and disease in ageing, and to develop evidence-based prevention, diagnostic, therapeutic and other strategies. The aim of this article, authored by the principal investigators of the 17 collaborating teams, is to describe briefly the rationale, aims, strategies and work packages of AwE for the purposes of sharing our ideas and plans with the biogerontological community in order to invite scientific feedback, suggestions, and criticism.
AB - Human longevity continues to increase world-wide, often accompanied by decreasing birth rates. As a larger fraction of the population thus gets older, the number of people suffering from disease or disability increases dramatically, presenting a major societal challenge. Healthy ageing has therefore been selected by EU policy makers as an important priority (http://www.healthyageing.eu/european-policies-and-initiatives); it benefits not only the elderly but also their direct environment and broader society, as well as the economy. The theme of healthy ageing figures prominently in the Horizon 2020 programme (https://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing), which has launched several research and innovation actions (RIA), like “Understanding health, ageing and disease: determinants, risk factors and pathways” in the work programme on “Personalising healthcare” (https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/693-phc-01-2014.html). Here we present our research proposal entitled “ageing with elegans” (AwE) (http://www.h2020awe.eu/), funded by this RIA, which aims for better understanding of the factors causing health and disease in ageing, and to develop evidence-based prevention, diagnostic, therapeutic and other strategies. The aim of this article, authored by the principal investigators of the 17 collaborating teams, is to describe briefly the rationale, aims, strategies and work packages of AwE for the purposes of sharing our ideas and plans with the biogerontological community in order to invite scientific feedback, suggestions, and criticism.
KW - Caenorhabditis elegans
KW - Healthspan
KW - Longevity Nutraceuticals
KW - Medicinal plants
KW - Natural products
UR - http://www.scopus.com/inward/record.url?scp=84962178057&partnerID=8YFLogxK
U2 - 10.1007/s10522-016-9644-x
DO - 10.1007/s10522-016-9644-x
M3 - Article
C2 - 27040825
AN - SCOPUS:84962178057
SN - 1389-5729
VL - 17
SP - 771
EP - 782
JO - Biogerontology
JF - Biogerontology
IS - 4
ER -